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Abstract 
 
Vision-related symptoms are one of the most common effects experienced after a 
concussion/mild traumatic brain injury regardless of age. Heightened sensitivity to light, and 
disturbances in sleep patterns are two of the most frequently diagnosed. While the exact etiology 
of these symptoms remains unknown, evidence suggest the potential involvement of intrinsically 
photosensitive ganglion cells (ipRGCs) which uniquely innervate both retinal and brain targets 
involved in photic adaptation and circadian rhythm regulation. Variation in ipRGC structure and 
function have been reported in other neurodegeneration conditions such as Parkinson’s, 
Alzheimer’s, glaucoma, and diabetic retinotopy, however, a direct assessment of ipRGCs after 
brain trauma remains incomplete. The current study investigated retinal ipRGCs morphometrics 
and anatomical integrity of injury induced neuroinflammation patters in ipRGC brain projection 
sites in a murine model of mild traumatic brain injury. The resulting data show significant 
dendritic and somal modifications in the retina, with ipRGCs of injured subjects with 
accompaniment of neuroinflammation in corresponding brain projections sites. These findings 
though preliminary illuminate the vulnerability of these unique retinal neurons to brain trauma 
and support additional investigation to fully characterize their role in the post-concussion visual 
syndrome paradigm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
1. Introduction 
 
1.1. Definitions and Epidemiology  
Traumatic brain injury (TBI) is defined as a disruption in normal functions of the brain 
caused by a bump, blow, jolt to the head, or penetrating head injury (CDC, 2014).  More 
specifically, TBI encompasses the functional deficits, neuroinflammation, and abnormal brain 
metabolism that is maintained for days to months after one of these traumatic events (Nilsson et 
al., 2019).  Often times TBI is confused with concussion despite the differences in their 
symptomologies.  Concussion, unlike TBI, presents abrupt symptoms resulting from a traumatic 
event to the brain and has a spontaneous recovery (Nilsson et al., 2019).  Sometimes concussions 
are synonymously noted as mild traumatic brain injury (mTBI) which is a somewhat 
inappropriate nomenclature considering TBI’s distinctly separate characterization.  Loss of 
consciousness and other transient symptoms are therefore concussion related and not an aspect of 
the TBI process. The spontaneity of recovery of concussions prevents it from being a treatable 
condition, rather a warning for resulting TBI.  The TBI pathological cascade of events can cause 
disastrous neurological impairment and if activated enough leads to neurological disease.  This 
disease has been characterized as chronic traumatic encephalopathy (CTE) and is associated with 
progressive neurodegeneration and significant, lasting cognitive deficits (Nilsson et al., 2019).  
Being that TBI is a result of concussion and a link to more debilitating CTE, the clinical 
relevance in this neurological impairment is profound especially when realizing TBI is not able 
to be treated directly.  
High incidence of mTBI provides additional clinical relevance for the study of this 
disease process. The highest rates of TBI are in children and young adults at a rate of 1081 per 
100,000 and 1591 per 100,000 people respectively. This age group commonly occur these 
injuries during sports and are incentivized to lower their recovery time as evident by extensive 
return to play guidelines to enforce proper recovery times (Coxe et al., 2018).  It is important to 
note that the age cohort of adults ≥75 years represent another high TBI affected population with 
2232 cases per 100,000 people but has less cases than all people under 18 years old.    
One of the main challenged in the search for TBI treatment is the classification of disease 
severity.  Like many disease processes, TBI has a variation of pathologies that cannot all be 
treated in the same way and will require accurate classification to be effective (Sidney Kimmel 
Medical College). Classification of traumatic brain injury severity has previously been identified 
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with a variety of methods including the Glasgow Coma Scale (GCS), Abbreviated Injury Scale 
(AIS), and various versions of the Sports Concussion Assessment Tool (SCAT) (Rodgers, 2018, 
Sargeant et al., 2018). Research is constantly being performed for a more specific classification 
system to more accurately group pathophysiological mechanisms (Saatman et al., 2010).  The 
categories laid out in many of these methods however still lead to improper classification and 
diagnostics to properly triage TBI patients (Lu et al., 2012).  More mild TBI patients potentially 
assume the most risk in this situation as they are often misdiagnosed and are left out of treatment 
attempts.  As a result, they often develop symptoms months later (Jones and Jarvis, 2017).    
1.2 Role of Neuroinflammation and the Secondary Cascade  
One of the reasons for poor diagnostic development is due to the wide spanning effects of 
TBI. A look into the molecular basis of TBI can illustrate why diagnostics and treatment options 
remain ineffective.  Beginning with the primary injury at the point of bump, blow, jolt, or 
penetration, along with the immediate effects, stimulates a cascade of varying pathologies. These 
include disruptions to cerebral blood flow causing edemas, increases in intracellular calcium of 
neurons, and the activation of catabolic proteins leading to neuronal degradation (Dickson and 
Weller, 2011).  This diffuse neuronal trauma, similar to the peripheral responses to injury, is 
exacerbated with the release of proinflammatory cytokines by glial cells that bathe surrounding 
tissue.  This results in a widespread secondary neurodegenerative cascade which has many 
different aspects, two of which being astrocytes and microgliosis (Dickson and Weller, 2011).  
Astrocytosis is characterized by hypertrophy and proliferation of reactive astrocytes in areas of 
injury within the brain (Sofroniew and Vinters, 2010).  An important characteristic of 
astrocytosis is the upregulation of glial fibrillary acid protein (GFAP) at all levels of pathological 
severity.  GFAP is a protein that is expressed by reactive astrocytes which are only seen under 
normal conditions in a subset of white matter tracts (Sofroniew and Vinters, 2010). Therefore, 
GFAP is a relevant biomarker that can be used to assess the presence of neuroinflammation and 
the integrity of brain tissue post-injury. Another aspect of the secondary neurodegenerative 
inflammatory response is the proliferation of activated microglia. Activated microglial while are 
beneficial in helping clean up and remove damaged neurons (Kettenmann et al., 2011) can 
become detrimental with sustained activity leading to stripping and phagocytosis of non-
damaged, normal functioning synapse in adjacent and distal after injury, thus perpetuating the 
neurodegenerative cascade (Hammond et al., 2018).  Adding to the diffuse character of TBI 
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pathology is microglial migration in amoebic form with evidence of migration as early as 24 
hours post-injury (Morgese et al., 1983).  Microglia are able to be identified in vivo by the 
protein, ionized calcium binding adaptor molecule (IBA1) (Kettenmann et al., 2011). 
Additionally, it has been identified that IBA1 concentrations increase after the activation of 
microglia indicating a positive correlation between microgliosis and expression levels 
(Kettenmann et al., 2011).  
Discussing the relationship of cytokines, astrocytes, and microglia can highlight the 
molecular aspects of TBI relevant in this study. The initial injury prompts local astrocytes and 
microglia to release proinflammatory cytokines while simultaneously adjusting their gene 
expression profiles (Jeon & Kim, 2016).  These responses cause astrocytosis and microgliosis of 
the local glia and the proinflammatory cytokines spread out randomly in the brain to activate 
more glial cells, perpetuating a cycle of gliosis (Dickson & Weller, 2011). This can be visualized 
in the brain post-mortem with the GFAP and IBA1 biomarkers which are upregulated as a part of 
the gene profile expression change.     
1.3 Role of the Visual System in TBI 
Visual related symptoms are common due to the large percentage of the brain dedicated 
to visual pathway integration.  The diffuse nature of TBIs therefore has a high chance of 
influencing pathways for these functions (Keller, 2012). Additionally, there are a host of 
symptoms with high prevalence in TBI patients related to non-image forming pathways such as 
photosensitivity or photophobia and circadian rhythm disruptions which are normally indicated 
by sleep disruptions (Barshikar and Bell, 2017). 
The retina contains many different types of cells including ganglion cells which are 
neurons sending visual information to the brain.  There are many types of ganglion cells 
including a specialized set which are able to convert light directly into electrical potentials and 
are therefore called intrinsically photoreceptive retinal ganglion cells (ipRCGs).  Because of 
these cells’ unique projection percentage to regions of the brain with significant functional 
overlap with TBI symptoms, they may be important in the case of TBI (Cui et al., 2015, Hattar et 
al., 2010). In general, this relationship has not been given much attention in the literature. One 
study assessing ipRGC function after TBI in military veterans showed an increase in photo 
potentiation response from TBI patients compared to controls (Hartwick, 2015).  This is 
indicative of ipRGCs being less able to adapt to light after a TBI which would represent an 
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obvious dysfunction from normal physiological function.  The study however did not investigate 
ipRGC morphological changes between patients, only the difference in functional response.  This 
leaves room for the exploration of morphological studies to more accurately investigate how 
ipRGCs might be influenced after a TBI.   
This project will attempt to identify a relationship between TBI and consequent ipRGC 
morphology. This relationship is important because there may be clinical relevance of 
diagnostics and interventional methods for TBI if the ipRGC dysfunctional context is better 
understood. A benefit of an ipRGC linkage is that it could associate TBI with changes in the eye, 
which is much more accessible to practitioners than the brain.  Additionally, visually related 
symptomologies, like photophobia and circadian rhythm disruption, have significant bodies of 
research which can potentially be linked together with an ipRGC and TBI relationship (Hayne 
and Martin, 2019, Aoun et al., 2019). To assess this potential impact on ipRGCS, this study will 
identify if a morphological change in ipRGCs will result after TBI in a mouse model.  The 
reason for injuring the visual cortex is to identify if the pathological response from more distal 
neurons to the ipRGCs will cause their preferential morphological change (Hubel and Wiesel, 
1972).  Though a TBI can disrupt deeper brain anatomy, it will likely have more of an impact on 
the more superficial structures, especially more moderate TBIs.  Having the CCI in the cortex 
rather than performing a lesion study more closely models the TBI injury paradigm (Osier and 
Dixon, 2018).  
 
2. Methods 
 
 
2.1 Subjects  
 
Male and female C57BL/6 mice were used in this study (Jackson Labs, stock # 000664). 
This strain is one of the most widely used strains in biomedical research and do not develop any 
retino-ocualar phenotypes making them best suited for this study. All mice were maintained in a 
12-hour light/dark cycle with water and standard rodent chow available ad libitum and housed in 
the same room under the same environmental conditions in the Comparative Medicine Unit at 
the Northeast Ohio Medical University (NEOMED). All experimental procedures were approved 
by the NEOMED Institutional Animal Care and Use Committee and conducted in accordance 
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with the Guide for Care and Use of Laboratory Animals published by the National Institutes of 
Health. 
 
2.2 Groups, Sample Size, and Ages 
 
Sixteen subjects were equally assigned into two-procedural groups: 1) Injury and 2) Control 
(Sham). Each procedural group utilized subjects in two-age groups: 1-month and 5-months. Age 
ranges were based on human equivalents to reflect an immature pediatric (1-month old mouse ≈ 
12.5-year old human) and mature young adult (5-month old mouse ≈ 27-year old human) 
population (Flurkey et al., 2007). 
  
2.3 Controlled Cortical Impact Injury Model   
 
Controlled cortical impact (CCI) is a well-established and widely used model of brain trauma 
that uses an electromagnetically controlled piston to induce a controlled, reproducible injury to 
an anesthetized animal subject secured within a stereotaxic apparatus (Osier and Dixon, 2018).  
 Mice were anesthetized with 3% inhaled isoflurane anesthesia and placed prone into a 
stereotaxic apparatus (Stoelting, Wood Dale, IL) with a nose cone delivering 2.5% isoflurane at 
0.8 ml/min. Normal body temperature was maintained using thermal heating elements 
underneath stereotaxic base. Scalp was shaved and sterilized with isopropyl alcohol and betadine 
solutions. To prevent eye drying and irritation topical GenTeal Tears gel (0.3 % Hypromellose) 
was applied. A midsagittal incision was performed to expose skull sutures. A craniotomy leaving 
dura intact was performed using 2-mm trephine over primary visual cortex (4.8 mm posterior 
and 2.5 mm from bregma). Following the craniotomy, the CCI impactor (1.5-mm diameter) was 
positioned within the cranial window to deliver single non-repeating impact (speed of 2 
meters/second, dwell time of 100 millisecond at a depth of 0.4 mm) to induce a mild traumatic 
brain injury within primary visual cortex. Following impact, the craniotomy was sealed using 
bone wax and the scalp was closed using VetBond tissue adhesive (3M).  
Additionally, mice received 1µl intravitreal injections of cholera toxin subunit-B 
conjugated to CF-488 (CTB488; Biotium) using 33-ga. Hamilton Syringe. CTB is readily taken 
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up and transported down the axons of RGCs and is used to safety and effectively locate retinal 
projections sites in post-mortem brain tissue.  
Following completion of surgical procedures, mice were allowed to fully recover from 
sedation and observed for any non-expected signs of stress or dysfunction before being returned 
to CMU. Observation of gross motor, pain, balance dysfunction, would indicate a more diffuse 
injury context than intended constituting removal from the study. Subjects within the control 
groups underwent a sham surgical procedure which replicated all aforementioned including 
craniotomy but did not receive a controlled cortical impact. 
 
     2.4 Tissue Collection  
 
All subjects one-week following surgery were sacrificed via anesthetic overdose (Fatal 
Plus, 120 mg/kg, i.p.) and were then transcardially perfused with 4% paraformaldehyde 
(PFA)/0.1M phosphate buffered saline (PBS). Whole eyes and brains were dissected from the 
skull, post-fixed for 1-hour and overnight in 4% buffered PFA, respectively. Retinas were 
dissected from the eyes, vitreous removed, and maintained as whole mount preparations for 
immunofluorescent staining. Brains were cryoprotected in 20% sucrose/PBS prior to sectioning. 
Coronal sections were taken at 40µm on a freezing/sliding microtome. 
 
     2.5 Immunofluorescence (IF)  
 
Whole-mount retina along with alternate series of brain sections containing the lateral 
geniculate nucleus (LGN), olivary pretectal nucleus (OPN), and suprachiasmatic nucleus (SCN)   
were assayed using IF labeling methods. Tissue was incubated at 37° C for 1 hour in a blocking 
solution containing 5% normal donkey serum and 0.1% Triton-X 100 in PBS, followed by 
overnight incubation at room temperature in a primary antibody solution containing 3% serum, 
0.1% Triton. Primary antibodies were used to label intrinsically photoreceptive ganglion cells in 
the retina (Anti-Melanopsin, 1:500; AB-N39, Advanced Targeting Systems), parenchymal 
reactive astrocytes (Anti-Glial fibrillary acidic protic, GFAP; 1:500; Millipore MAB360), and 
microglia/macrophages (Anti-ionized calcium-binding adapter molecule 1, IBA1; 1:500; Abcam 
ab5076). After primary incubation, tissue was washed 3x in PBS for 10 minutes and then 
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incubated at room temperature for 2 hours in CF-Dye conjugated (594, 647, and 755 dyes) 
secondary antibody solution (Biotium, San Francisco, CA) at a dilution of 1:200 in PBS 
containing 1% serum and 0.1% Triton. After 3 final PBS washes (10 minutes each), tissue was 
mounted onto slides and coverslipped ProLong Glass with NucBlue (ThermoFisher). 
 
     2.6 Microscopy  
 
Retina and brain tissue samples were imaged on a Zeiss Axio Imager M2 (Hamamatsu 
Flash4.0 V3 Digital CMOS; Japan) epifluorescent microscope equipped with an Apotome.2 
structured illumination system for obtaining optically sectioned images, a motorized Z and X-Y 
stage, and Zen 2 operating software with deconvolution, tiling, and extended-depth-of-focus 
modules. Retinal whole-mount reconstructions were obtained by imaging for Melanopsin 
immunofluorescence using the Plan-Apochromat 20x/0.8 objective across multiple adjacent 
frames with 10% overlap. Multi-frame tiles were stitched using the Zen Pro 2.3 software (Zeiss; 
Jena, Germany) to eliminate overlap. To assess parenchymal inflammation across ipRGCs 
projections sites, we used intravitreal transported CTB-488 florescent signal to help locate 
projection sites and then captured IBA1 and GFAP label with region of interest using Axio 
Imager/apotome system. 
 
     2.7 Data Analysis  
  
Image Pro Premier software (Media Cybernetics) was used to generate automated counts 
of Melanopsin labelled RGCs soma from images of whole-mount retina (adapted from Dengler-
Crish et al., 2014) as well as determine somal size and number of dendritic branch points. For 
Melanopsin -positive RGC in each retina were plotted and then the total was then divided by the 
total area (mm2) of the retina to compute ipRGC density. For somal and dendritic analysis a sub-
sampling of 5-10 melanopsin-positive RGCs restricted to the dorsal retina were analyzed axons 
all groups. 
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   2.8 Statistical Analysis  
 
 All statistical analyses were conducted using SPSS software (IBM; Armonk, NY). A 2 x 
2 factorial analyses of variance (ANOVA) were used to test for main effects of injury condition 
(Injured; Non-injured) and age (1-month, 5-month) as well as for significant interactions for each 
dependent variable of interest (cell density, somal area, number of branch points). Bonferroni-
corrected post-hoc tests were used to assess subgroup differences. 
 
 
3. Results 
 
3.1 ipRGCs morphological is altered in post-TBI retina  
 
Melanopsin stained ipRGCs in the contralateral dorsal retina of 1-month old mice following 
mTBI revealed a significant reduction in number of dendritic branching (F3,16 = 10.63, p < 0.05; 
Figure 1A&B) and somal area (F3,16 = 8.76, p < 0.05; Figure 1C) compared to age-matched 
non-injured controls. Unlike the 1-month old subjects, injured 5-month old subjects did not show 
a statically significant difference in ipRGC dendric arbor complexity (F3,16 = 8.76, p < 0.05; 
Figure 1B), however, 5-month old injured ipRGC soma were significantly smaller compared to 
non-injured controls (F3,16 = 8.76, p < 0.05; Figure 1B) and to ipRGC soma in injured 1-month 
old retina (F3,16 = 8.76, p < 0.05; Figure 1B).  
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Figure 1. Flat mounted melanopsin stained ipRGC (red) images and tracing from a; 1 month old (top row) 5-
month (bottom row) old control (left) and TBI (right) mouse retina. From this image it can be seen that 
ipRGCs in TBI retina exhibit less complex arborization pattern than compared to non-injured age-
matched controls. (BAR GRAPH) Number of branch points plotted across experimental and control groups. 
1- month old mouse retina graphed on the left with control and TBI retina being represented by yellow 
and purple bars respectively.  5-month-old mouse retina graphed on the right with control and TBI retina also 
being represented by yellow and purple bars respectively.  Each bar height represents that average branch point 
count of the analyzed ipRGCs along with standard error bars. Somal area in μm2 is plotted across experimental 
and control groups.  1 month old mouse retina graphed on the left with control and TBI retina being 
represented by yellow and purple bars respectively.  5 month old mouse retina graphed on the right with 
control and TBI retina also being represented by yellow and purple bars respectively.  Each bar height 
represents that somal area of the analyzed ipRGCs along with standard error bars.  The star represents 
significant differences of p<0.05.    
 
 
      
 
 
 12 
     3.2 Age-dependent loss of IpRGCs post TBI  
 
Cell density is another morphological metric.  This measurement indicates an extreme 
morphological pattern of apoptosis where the entire morphology of the cell degrades.  The extent 
of apoptosis can be indicated by cell density whereas the lower cell density can indicate a higher 
incidence of apoptosis.  In Figure 4 the cell densities across the four groups can be seen to see 
which have been influenced by this extreme morphological change.  The graph illustrates that the 
5 month TBI retinas had a lower cell density compared to the controls.  Additionally, it can be 
seen that both the one month groups and the 5 month control were found to have no statistical 
difference in cell density. These results are evident of a preferential effect in older mice as the 
only statistical difference was between the 5 month groups. 
 
 
 
Figure 2. Cell density as cells/mm2 is plotted across experimental and control groups. 1 month old mouse 
retina graphed on the left with control and TBI retina being represented by yellow and purple bars 
respectively.  5 month old mouse retina graphed on the right with control and TBI retina also being represented 
by yellow and purple bars respectively.  Each bar height represents that somal density of the ￼￼analyzed 
ipRGCs along with standard error bars.  The star represents significant differences of p<0.05.    
 
   
 
3.3.Neuroinflammation in ipRGC brain projection sites    
  
CTB488 staining, in green, identified structures in the brain directly synapsing with 
ipRGCs.  This allowed for the outlining of the suprachiasmatic nucleus (SCN) in Figure 3, the 
olivary pretectal nucleus (OPN) in Figure 4, and the lateral geniculate nucleus (LGN) in Figure 
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5. The SCN of 1 month mTBI mice exhibited higher GFAP and IBA1 labeling qualitatively 
compared to age-matched non-injured controls (Figure 3 columns 3&4).  The OPN did not show 
qualitative differences in labeling between 1 and 5 month mTBI mice compared to the 1 month 
non-injured control (Figure 4 columns 3&4).  Finally, the LGN showed a unique pattern of 
GFAP and IBA labeling.  The 1 month mTBI and age matched controls showed no qualitative 
difference in LGN labeling (Figure 5 columns 3&4, rows 1&2).  The 5 month mTBI LGN 
however did show an increase in labeling compared to both one month mice, but only in the inter 
geniculate leaflet (IGL) (Figure 5 columns 3&4).   
 
 
    
 
Figure 3. The suprachiasmatic nucleus (SCN) immunofluorescent images indicate glial activation in a control 
(top row) and TBI induced (bottom row) mouse brain. CTB488 expression can be seen in green (column 2), 
GFAP in magenta (column 3), and IBA1 in yellow (column 4).  An overlapped image of all three protein 
expression images can be seen in column 1.   
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Figure 4.  The olivary pretectal nucleus (OPN) immunofluorescent images indicate a lack of glial activation in 
a 1 month control (top row) and a 1 month and 5 month TBI induced (middle and bottom row respectively) 
mouse brain. CTB488 expression can be seen in green (column 2), GFAP in magenta (column 3), and IBA1 in 
yellow (column 4).  An overlapped image of all three protein expression images can be seen in column 1.  
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Figure 5.  The lateral geniculate (LGN) immunofluorescent images indicate no glial activation in a 1 month 
control (top row) and some activation in a 1 month and 5 month TBI induced (middle and bottom row 
respectively) mouse brain. CTB488 expression can be seen in green (column 1), GFAP in magenta (column 2), 
and IBA1 in yellow (column 3).   
 
 
 
4. Discussion  
 
 In this study we began by assessing the change in cellular morphology of M1 ipRGCs 
after TBI by staining the retina with melanopsin.  Melanopsin stained ipRGCs were imaged in 
both TBI influenced and control mice.  The three morphological metrics quantified from these 
images were somal area, dendritic branch points, and cell density. Together, these quantitative 
results can illustrate a holistic depiction of how ipRGC morphology changes across the cell.  
Interpreting the results of these three metrics together is important as different aspects of the cell 
can be differentially influenced by the TBI condition.  These three metrics are a common way to 
account for the entire cell for morphological changes in ipRGCs (Lee & Schmidt, 2018). Results 
indicated a decrease in the number of branch points in the TBI induced 1-month old mice 
compared to controls.  This suggests ipRGC morphological change after TBI in the younger age 
group.  There was not a significant difference between the TBI and controls in the 5-month old 
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groups.  This specific age variation in the branch point metric could be a result of ipRGC injury 
resistance that has been described in previous studies (Cui et al., 2015, Berry et al., 2019).  
Specifically, dendritic complexity measured by branch point counts has been indicated to remain 
static following proximal injury in previous studies using mice of a similar age (Tran et al., 
2019).  Since there was a significant decrease of dendritic complexity in our younger TBI mice 
but not the older, it seems that there may be an age-related correlation between changes in this 
type of morphology.  Though this could easily be a result of having too few subjects, this trend 
could be particularly troubling as the major age group suffering from TBIs are the pediatric 
population which the 1 month old mice represent.  It has been noted in optic nerve crush studies 
of mice 6-20 weeks of age, representing an adult neurological system, that ipRGCs are able to 
maintain dendritic complexity after injury.  This was indicated by a lack of significant variation 
in dendritic area or arborization complexity (Tran et al., 2019). Though an optic nerve crush 
injury is a more proximal pathology than the TBI, it is relevant that this preliminary data aligns 
with documented adult ipRGC morphological trends.  There is also literature suggesting a 
continuity of ipRGC function from pediatric through adult populations which seems to be 
countered by the data collected in this study (Adhikari et al, 2015).  
The results from the somal size analysis indicated that both 1-month and 5-month groups 
saw a significantly decreased somal size in TBI induced mice compared to controls. It was also 
discovered that the 5-month old TBI somas were significantly smaller than the 1-month TBI 
somas.  These results are interesting as they suggest a morphological change at all ages after 
suffering a TBI.  A lack of age-related results presents as an inconsistency with the previous 
morphological metric which suggested the opposite. Some studies confer these results by 
indicating ipRGC cell soma size changes in relation to nerve injury by quickly swelling followed 
by apoptotic degradation of somal area (Ingham et al., 2009, Brännström et al., 1992).  Changes 
in soma size indicate functional changes due to cellular form following function.  Though 
functional differences were not described in this study, there is literature indicating this ipRGC 
functional change after TBI to complement this interpretation (Hartwick, 2015).   
The final ipRGC morphological metric derived from this study was ipRGC cell density.  
This quantitative data provides evidence for the amount of neuron degeneration in the retina. 
Compared to controls, only the 5-month old TBI induced retina showed a significant decrease in 
cell density. This indicates an age-related effect where older ipRGCs are preferentially affected.  
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Many studies have already analyzed how ipRGC density is affected after injury.  In nerve crush 
studies it has been noted that RGC degeneration occurs in mice as young as 1-3 months old 
(Daniel et al., 2018). Other injury types such as retinal damage by intraocular pressure elevation 
showed decreasing protective effects as mice reached 11 months of age (Cui et al., 2015).  This 
is interesting as it suggests injury resistance variation across age. More distal injury, such as a V1 
cortical lesion, promotes inflammation and is associated with the atrophy of several other neural 
structures like the thalamus (Vigeveno et al., 2012).  These findings align with the hypothesized 
link between TBI pathology resulting in the V1 region and promoting morphological changes in 
distant brain regions.  
IpRGCs have diverged from other ganglion cell trends in many studies by exhibiting 
significantly higher survival percentages after proximal injury like an optic nerve crush 
(Vasalauskaite et al., 2019, Cui et al., 2015). Though there are studies citing M1 ipRGCs are not 
injury resistant in a neurodegenerative context (Lin et al., 2019), it is interesting that there is 
evidence that ipRGCs are exhibiting significant degeneration in this study. This could indicate 
TBI creates an environment where neuroprotective effects typically seen in ipRGCs are not 
effective.  Potentially, inflammatory signaling is playing a role in deleteriously influencing older 
mice ipRGCs, similar to the effects of intraocular pressure (IOP) build up during glaucoma in the 
adult eye (Zavalía et al., 2011).   Another potential facet of these results is the noted 
downregulation of melanopsin production after injury (Nadal-Nicolás et al., 2015).  This was 
noted in mice after optic nerve injury but could indicate that the TBI context is causing a 
downregulation of melanopsin and cells are not being identified because of the experimental 
method rather than apoptosis.  Further studies controlling for this effect would increase the 
confidence of the ipRGC cell density results.  
Overall, the morphological metrics put together can start to describe a holistic effect the 
TBI has on ipRGCs.  In each of the morphological metrics, there was at least one significant 
difference in TBI retina compared to controls.  This supports the hypothesis that there will be 
morphological variations in ipRGCs after TBI.  These results provide promising evidence for this 
case and encourages pursuing this hypothesis to solidify results with more data.  The age-related 
effects however have variability in these cases that suggest a lack of consistent age-related 
morphological differences.  Because the branch point indicated a significant morphological 
difference in 1-month ipRGCs only while cell density saw a significant difference in the 5-month 
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ipRGCs only, there is evidence for a complex age related variation in morphology. There are 
other mechanisms in which morphology of ipRGCs change independent of injury.  It has been 
noted that process like late aging causes morphological variations in dendritic complexity of 
ipRGCs along with general ipRGC neuronal loss in degenerative diseases like Alzheimer’s 
disease (Esquiva et al., 2017, Morgia et al., 2015, Lucas et al, 2003).  There are also 
immunotoxins that can influence ipRGC morphology stimulated by mechanisms other than TBI 
(Ingham et al., 2009).  These ipRGC influences should be controlled to prevent confounding 
morphological data.    
To draw a more concrete link between the pathology of the brain to ipRGCs, brain tissue 
was analyzed in areas that link ipRGCs and the impacted cortical region.  The biomarker analysis 
is likely indicating astrocyte hypertrophy and a microglial proliferation due to the common 
responses of these glia after this cortical injury type (Amat et al., 1996).  This diverges from 
degenerative disease processes where both microglia and astrocytes can be seen to proliferate 
(McLean et al., 2005). The SCN images indicated an increase in gliosis biomarkers in the TBI 
induced mouse implying TBI was involved in creating a pathology at V1 which spread to the 
SCN.  The same result is shown by the intergeniculate leaflet of the LGN.  Both of these nuclei 
show how inflammatory pathology is traveling the pathway from V1 injury site to ipRGCs.  The 
OPN surprisingly did not show gliosis signaling despite also being a nucleus with a high ipRGC 
projection percentages in mice and primates (Hannibal et al., 2015, Morin & Studholme, 2015).  
There could be a variety of reasons for this result, potentially sharing less output neurons with 
the specific V1 region that got the CCI compared to other nuclei. A longer timeframe may also 
be needed to notice the neuroinflammation in subcortical areas like the OPN. 
Neuroinflammatory responses can be maintained in neural parenchyma up to 6 months after 
initial pathology (Caplan et al., 2015, Kumar et al., 2015). Overall, the results from the stained 
nuclei illustrate a somewhat consistent connection of pathology from the area of CCI to ipRGCs 
by way of specific intermediary sites in the brain.  
 The results from this experiment provide a proof of concept for further work on 
morphological analysis of ipRGCs after traumatic brain injury.  A small sample size presented in 
this study is enough to decide the value of pursuing this work, but not enough to confidently 
support or refute the hypothesis.  Adding more mice to control and experimental groups could 
strengthen the argument one way or another and is a task the lab plans to entertain in the future. 
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Additionally, the brain segment studies all appeared in qualitative form for this analysis.  The 
creation of heat maps and illuminance to background metrics will aid in the qualitative 
evaluation of the pathological tract from injury to ipRGCs.  Additional studies on the ipRGC 
physiological function after TBI could complete the form and function connection.  Using a 
patterned electroradiograph (PERG) experiment could be used to indicate ganglion cell 
functioning and would be useful in generating complementary physiological data (Holder, 2001).  
A blue red pupillometer recording could also be used to generate this type of data (Hartwick, 
2015).   
 
5. Conclusion   
  
 The results from this preliminary data analysis indicate that there is a morphological 
impact on ipRGCs after traumatic brain injury.  Due to the low sample size of the study, this 
trend is useful for indicating further experimentation rather than creating a confident statement 
for or against the hypothesis. Specific age-related effects seem to be a complicated facet of the 
ipRGC morphological response and may require the utilization of various different studies to 
provide an accurate depiction.   
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